T1	AdverseReaction 116 145	Nephrogenic systemic fibrosis
T2	AdverseReaction 147 150	NSF
T3	AdverseReaction 219 245	Hypersensitivity reactions
T4	AdverseReaction 390 396	nausea
T5	AdverseReaction 398 406	headache
T6	AdverseReaction 408 419	feeling hot
T7	AdverseReaction 421 430	dizziness
T8	AdverseReaction 436 445	back pain
T9	AdverseReaction 1528 1534	nausea
T10	AdverseReaction 1536 1544	headache
T11	AdverseReaction 1546 1557	feeling hot
T12	AdverseReaction 1559 1568	dizziness
T13	AdverseReaction 1574 1583	back pain
T14	AdverseReaction 1850 1856	Nausea
T15	AdverseReaction 1914 1922	Headache
T16	AdverseReaction 1978 1989	Feeling hot
T17	AdverseReaction 2042 2051	Dizziness
T18	AdverseReaction 2106 2115	Back pain
T19	AdverseReaction 2170 2178	Vomiting
T20	AdverseReaction 2234 2258	Blood pressure increased
T21	AdverseReaction 2298 2322	Injection site reactions
T22	AdverseReaction 2298 2312;2324 2328	Injection site reactions (pain
T23	AdverseReaction 2298 2312;2330 2337	Injection site reactions (pain, burning
T24	AdverseReaction 2298 2312;2339 2347	Injection site reactions (pain, burning, coldness
T25	AdverseReaction 2298 2312;2349 2362	Injection site reactions (pain, burning, coldness, extravasation
T26	AdverseReaction 2298 2312;2364 2374	Injection site reactions (pain, burning, coldness, extravasation, irritation
T27	AdverseReaction 2400 2409	Dysgeusia
T28	AdverseReaction 2464 2475	Paresthesia
T29	AdverseReaction 2528 2536	Flushing
T30	AdverseReaction 2592 2600	Parosmia
T31	AdverseReaction 2656 2664;2666 2677	Pruritus (generalized
T32	AdverseReaction 2656 2664;2679 2682	Pruritus (generalized, eye
T33	AdverseReaction 2720 2724	Rash
T34	AdverseReaction 2784 2805	Respiratory disorders
T35	AdverseReaction 2807 2814	dyspnea
T36	AdverseReaction 2816 2836	respiratory distress
T37	AdverseReaction 2862 2869	Fatigue
T38	AdverseReaction 2926 2936	Chest pain
T39	AdverseReaction 2990 2997	Vertigo
T40	AdverseReaction 3054 3063	Dry mouth
T41	AdverseReaction 3118 3124	Chills
T42	AdverseReaction 3182 3198	Feeling abnormal
T43	AdverseReaction 3352 3358	tremor
T44	AdverseReaction 3360 3369	akathisia
T45	AdverseReaction 3371 3390	bundle branch block
T46	AdverseReaction 3392 3403	palpitation
T47	AdverseReaction 3405 3420	oral discomfort
T48	AdverseReaction 3422 3445	salivary hypersecretion
T49	AdverseReaction 3447 3465	maculopapular rash
T50	AdverseReaction 3467 3480	hyperhidrosis
T51	AdverseReaction 3482 3492	discomfort
T52	AdverseReaction 3498 3505	malaise
T53	AdverseReaction 3511 3534	Elevation of serum iron
T54	AdverseReaction 3511 3523;3546 3561	Elevation of serum iron values and serum bilirubin
T55	AdverseReaction 4107 4133	Hypersensitivity reactions
T56	AdverseReaction 4135 4152	anaphylacticshock
T57	AdverseReaction 4154 4165	hypotension
T58	AdverseReaction 4167 4190	pharyngolaryngeal edema
T59	AdverseReaction 4192 4201	urticaria
T60	AdverseReaction 4203 4213	face edema
T61	AdverseReaction 4215 4223	rhinitis
T62	AdverseReaction 4225 4239	conjunctivitis
T63	AdverseReaction 4241 4255	abdominal pain
T64	AdverseReaction 4257 4269	hypoesthesia
T65	AdverseReaction 4271 4279	sneezing
T66	AdverseReaction 4281 4286	cough
T67	AdverseReaction 4291 4297	pallor
T68	AdverseReaction 4348 4359	Tachycardia
T69	AdverseReaction 4367 4379	Restlessness
T70	AdverseReaction 4411 4440	NEPHROGENIC SYSTEMIC FIBROSIS
T71	AdverseReaction 4442 4445	NSF
T72	AdverseReaction 4459 4488	NEPHROGENIC SYSTEMIC FIBROSIS
T73	AdverseReaction 4490 4493	NSF
T74	DrugClass 4500 4532	Gadolinium-based contrast agents
T75	AdverseReaction 4563 4566	NSF
T76	AdverseReaction 4769 4772	NSF
T77	Factor 4773 4776	may
T78	AdverseReaction 4787 4792	fatal
T79	Severity 4796 4808	debilitating
T80	AdverseReaction 4809 4817	fibrosis
T81	Factor 4879 4883	risk
T82	AdverseReaction 4888 4891	NSF
T83	AdverseReaction 5571 5600	NEPHROGENIC SYSTEMIC FIBROSIS
T84	AdverseReaction 5602 5605	NSF
T85	DrugClass 5682 5714	Gadolinium-based contrast agents
T86	AdverseReaction 5745 5748	NSF
T87	Factor 5965 5969	risk
T88	AdverseReaction 5974 5977	NSF
T89	AdverseReaction 6457 6486	Nephrogenic Systemic Fibrosis
T90	AdverseReaction 6662 6675;6693 6702	anaphylactoid/hypersensitivity reactions
T91	AdverseReaction 6676 6702	hypersensitivity reactions
T92	AdverseReaction 6708 6722;6750 6764	cardiovascular, respiratory and cutaneous manifestations
T93	AdverseReaction 6724 6735;6750 6764	respiratory and cutaneous manifestations
T94	AdverseReaction 6740 6764	cutaneous manifestations
T95	Severity 6779 6783	mild
T96	Severity 6787 6793	severe
T97	AdverseReaction 6814 6819	shock
T98	Factor 6820 6823	can
T99	DrugClass 6971 7003	Gadolinium-based contrast agents
T100	Factor 7025 7029	risk
T101	AdverseReaction 7034 7063	nephrogenic systemic fibrosis
T102	AdverseReaction 7065 7068	NSF
T103	DrugClass 7286 7290	GBCA
T104	AdverseReaction 7302 7305	NSF
T105	AdverseReaction 7659 7662	NSF
T106	Factor 7663 7666	may
T107	AdverseReaction 7677 7682	fatal
T108	Severity 7686 7698	debilitating
T109	AdverseReaction 7699 7707	fibrosis
T110	Factor 8560 8564	risk
T111	AdverseReaction 8569 8572	NSF
T112	AdverseReaction 9315 9327;9355 9364	Anaphylactic and other hypersensitivity reactions
T113	AdverseReaction 9338 9364	hypersensitivity reactions
T114	AdverseReaction 9370 9384;9412 9426	cardiovascular, respiratory and cutaneous manifestations
T115	AdverseReaction 9386 9397;9412 9426	respiratory and cutaneous manifestations
T116	AdverseReaction 9402 9426	cutaneous manifestations
T117	Severity 9441 9445	mild
T118	Severity 9449 9455	severe
T119	AdverseReaction 9467 9472	shock
T120	Factor 9751 9755	risk
T121	AdverseReaction 9762 9787	hypersensitivity reaction
T122	AdverseReaction 10009 10025;10102 10119	hypersensitivity reactions to EOVIST have occurred within half an hour after administration. Delayed reactions
T123	Factor 10120 10123	can
T124	AdverseReaction 10371 10390	acute kidney injury
T125	DrugClass 10459 10464	GBCAs
T126	Factor 10470 10474	risk
T127	AdverseReaction 10478 10497	acute kidney injury
T128	AdverseReaction 10707 10721;10874 10896	Injection Site Reactions



  Ensure catheter and venous patency before the injection of EOVIST. Extravasation into tissues during EOVIST administration may result in local tissue reactions
T129	Factor 10860 10863	may
R1	Hypothetical arg1:T75 arg2:T74
R2	Hypothetical arg1:T78 arg2:T77
R3	Hypothetical arg1:T80 arg2:T77
R4	Effect arg1:T80 arg2:T79
R5	Hypothetical arg1:T82 arg2:T81
R6	Hypothetical arg1:T86 arg2:T85
R7	Hypothetical arg1:T88 arg2:T87
R8	Hypothetical arg1:T90 arg2:T98
R9	Hypothetical arg1:T91 arg2:T98
R10	Effect arg1:T92 arg2:T95
R11	Effect arg1:T92 arg2:T96
R12	Hypothetical arg1:T92 arg2:T98
R13	Effect arg1:T93 arg2:T95
R14	Effect arg1:T93 arg2:T96
R15	Hypothetical arg1:T93 arg2:T98
R16	Effect arg1:T94 arg2:T95
R17	Effect arg1:T94 arg2:T96
R18	Hypothetical arg1:T94 arg2:T98
R19	Hypothetical arg1:T97 arg2:T98
R20	Hypothetical arg1:T101 arg2:T99
R21	Hypothetical arg1:T102 arg2:T99
R22	Hypothetical arg1:T104 arg2:T103
R23	Hypothetical arg1:T105 arg2:T106
R24	Hypothetical arg1:T107 arg2:T106
R25	Hypothetical arg1:T109 arg2:T106
R26	Effect arg1:T109 arg2:T108
R27	Hypothetical arg1:T111 arg2:T110
R28	Effect arg1:T114 arg2:T117
R29	Effect arg1:T114 arg2:T118
R30	Effect arg1:T115 arg2:T117
R31	Effect arg1:T115 arg2:T118
R32	Effect arg1:T116 arg2:T117
R33	Effect arg1:T116 arg2:T118
R34	Hypothetical arg1:T121 arg2:T120
R35	Hypothetical arg1:T122 arg2:T123
R36	Hypothetical arg1:T124 arg2:T125
R37	Hypothetical arg1:T127 arg2:T126
R38	Hypothetical arg1:T128 arg2:T129
N1	Reference T1 meddra:10067467	Nephrogenic systemic fibrosis
N2	Reference T2 meddra:10067467	Nephrogenic systemic fibrosis
N3	Reference T3 meddra:10020751	Hypersensitivity
N4	Reference T4 meddra:10028813	Nausea
N5	Reference T5 meddra:10019211	Headache
N6	Reference T6 meddra:10016334	Feeling hot
N7	Reference T7 meddra:10013573	Dizziness
N8	Reference T8 meddra:10003988	Back pain
N9	Reference T19 meddra:10047700	Vomiting
N10	Reference T20 meddra:10005750	Blood pressure increased
N11	Reference T21 meddra:10022095	Injection site reaction
N12	Reference T22 meddra:10022086	Injection site pain
N13	Reference T23 meddra:10022086	Injection site pain
N14	Reference T24 meddra:10050082	Injection site coldness
N15	Reference T25 meddra:10022062	Injection site extravasation
N16	Reference T26 meddra:10022079	Injection site irritation
N17	Reference T27 meddra:10013911	Dysgeusia
N18	Reference T28 meddra:10033775	Paraesthesia
N19	Reference T29 meddra:10016825	Flushing
N20	Reference T30 meddra:10034018	Parosmia
N21	Reference T31 meddra:10052576	Pruritus generalised
N22	Reference T32 meddra:10052140	Eye pruritus
N23	Reference T33 meddra:10037844	Rash
N24	Reference T34 meddra:10038683	Respiratory disorder
N25	Reference T35 meddra:10013968	Dyspnoea
N26	Reference T36 meddra:10038687	Respiratory distress
N27	Reference T37 meddra:10016256	Fatigue
N28	Reference T38 meddra:10008479	Chest pain
N29	Reference T39 meddra:10047340	Vertigo
N30	Reference T40 meddra:10013781	Dry mouth
N31	Reference T41 meddra:10008531	Chills
N32	Reference T42 meddra:10016322	Feeling abnormal
N33	Reference T43 meddra:10044565	Tremor
N34	Reference T44 meddra:10001540	Akathisia
N35	Reference T45 meddra:10006578	Bundle branch block
N36	Reference T46 meddra:10033557	Palpitations
N37	Reference T47 meddra:10030973	Oral discomfort
N38	Reference T48 meddra:10039424	Salivary hypersecretion
N39	Reference T49 meddra:10037868	Rash maculo-papular
N40	Reference T50 meddra:10020642	Hyperhidrosis
N41	Reference T51 meddra:10013082	Discomfort
N42	Reference T52 meddra:10025482	Malaise
N43	Reference T53 meddra:10005620	Blood iron increased
N44	Reference T54 meddra:10005364	Blood bilirubin increased
N45	Reference T56 meddra:10002199	Anaphylactic shock
N46	Reference T57 meddra:10021097	Hypotension
N47	Reference T58 meddra:10023845	Laryngeal oedema
N48	Reference T59 meddra:10046735	Urticaria
N49	Reference T60 meddra:10016029	Face oedema
N50	Reference T61 meddra:10039083	Rhinitis
N51	Reference T62 meddra:10010741	Conjunctivitis
N52	Reference T63 meddra:10000081	Abdominal pain
N53	Reference T64 meddra:10020937	Hypoaesthesia
N54	Reference T65 meddra:10041232	Sneezing
N55	Reference T66 meddra:10011224	Cough
N56	Reference T67 meddra:10033546	Pallor
N57	Reference T68 meddra:10043071	Tachycardia
N58	Reference T69 meddra:10038743	Restlessness
N59	Reference T78 meddra:10011906	Death
N60	Reference T80 meddra:10016642	Fibrosis
N61	Reference T90 meddra:10002216	Anaphylactoid reaction
N62	Reference T92 meddra:10075534	Cardiovascular symptom
N63	Reference T93 meddra:10075535	Respiratory symptom
N64	Reference T94 meddra:10075531	Cutaneous symptom
N65	Reference T97 meddra:10040560	Shock
N66	Reference T112 meddra:10002198	Anaphylactic reaction
N67	Reference T121 meddra:10020751	Hypersensitivity
N68	Reference T122 meddra:10053613	Type IV hypersensitivity reaction
N69	Reference T124 meddra:10069339	Acute kidney injury
N70	Reference T128 meddra:10022095	Injection site reaction
